UBS upgrads CLOV to Neutral — Price Target $4.75 (11-Jun-2026)

UBS analyst Jonathan Yong who covers CLOV has the current 5th biggest price target movement on AnaChart (11-Jun-2026 (2PM)) by upgrading from $2.75 to $4.75 with a decrease in potential downside change from $2.14(43.76%) to $0.14(2.86%) with a rating of Neutral